Lung and bronchial system (Neoplasia)

LE WE PMID CA

Lung and bronchial system (Neoplasia)

1650

Lunge und Bronchialsystem (Neubildung)

Antineoplastic agents (Resistance)

Arthritis (rheumatoid)

Asbestos

Bacillus calmette guerin

Bartonella henselae

Bortezomib ttProteasom

BRG1 SMARCA4

Bronchioloalveolar carcinoma

Bronchoscopy (BASKET)

Calcium (Hypercalciemia)

Candida (BASKET)

Carney s complex

Caspase9b

Cdh1

Cetuximab ttEGFR

Chemoprevention

Chromoendoscopy

Cisplatin

Coccidioidomycosis

COPD

Crohn s disease

Cryptococcosis

Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia

Endotoxin

Erlotinib ttEGFR

Fat necrosis subcutaneous of the newborn

Gastrointestinal stromal cell tumor GIST

Gefitinib ttEGFR

Haemophilus influenzae

Histoplasmosis

IGFBP3

Langerhans cell histiocytosis

Lepra

Lipidomics

Liver (Diseases)

LKB1

Lung (CT)

Lung (Diseases interstitial)

Lung (Lipoid pneumonia)

Lung (Neoplasia epitheloid haemangioendothelioma)

Lung (Neoplasia Pulmonary blastoma)

Lung (Resection)

Lung (Toxicology)

Lung and bronchial system (Neoplasia)

Lymphoma (BASKET)

Lymphoma (Hodgkin)

Mesothelioma

Mycobacterium avium

Nedaplatin

Neoplasia (Carcinogenesis)

Neoplasia (Radiofrequency ablation)

Neuroendocrine System (Neoplasia Carcinoid)

Neuroendocrine system (Neoplasia)

Osteoarthritis

Ovary (Neoplasia)

Paracoccoidomycosis

Pemetrexed

Photodynamic oncologic treatment

Pleura (Neoplasia)

Pneumocystis carinii Pneumocystis jirovicii

Polymyositis

Pro gastrin releasing peptide

Proteasome (BASKET)

Pseudolymphoma (Lymphomatoid granulomatosis)

Pseudolymphoma (Plasma cell granuloma)

Pulmonary pleomorphic carcinoma

Radiation therapy

RNA (MicroRNA)

Sarcoidosis

Silicone

Slack skin disease

Stomach (Neoplasia)

SWI SNF

Testis (Neoplasia Seminoma)

Testis (Neoplasia)

Thorax (CT)

Thorax (Video assisted thoracoscopy)

Tomosynthesis

Topotecan

Tuberculosis

Vandetanib

Vinflunine

Wegener s granulomatosis

2009 1	Tools used in the diagnosis and staging of lung cancer: what's old and what's new? [19372092] QJM 102(7): 443-8 (2009)
2009 2	Lung cancer: current diagnosis and treatment. [20038979] Dtsch Arztebl Int 106(49): 809-18; quiz 819-20 (2009)
2008 3	Adjuvant chemotherapy after complete resection of non-small cell lung cancer. [19629205] Dtsch Arztebl Int 105(14): 249-54 (2008)
2008 4	Complete mediastinal lymphadenectomy: the core component of the multidisciplinary therapy in resectable non-small cell lung cancer. [18457958] Eur J Cardiothorac Surg 34(1): 187-95 (2008)
2004 5	Surgical treatment of Pancoast tumours. [15201002] Eur J Cardiothorac Surg 26(1): 202-8 (2004)
2003 6	Pulmonary large-cell neuroendocrine carcinoma (LCNEC). [12694759] Eur J Cardiothorac Surg 23(4): 457-60 (2003)
2000 7	Long-term outcome after resection for bronchial carcinoid tumors. [10925223] Eur J Cardiothorac Surg 18(2): 156-61 (2000)
2000 8	Mucoepidermoid bronchial tumors: a review of 34 operated cases. [10814920] Eur J Cardiothorac Surg 17(5): 566-9 (2000)
1998 9	Localized fibrous tumours of the pleura: 15 new cases and review of the literature. [9860200] Eur J Cardiothorac Surg 14(5): 453-9 (1998)
1993 10	Diagnosis and treatment of bronchial carcinoid tumors: clinical and pathological review of 120 operated patients. [8431307] Eur J Cardiothorac Surg 7(1): 8-11 (1993)
1993 11	Bronchial carcinoids. [8396950] Eur J Cardiothorac Surg 7(7): 347-50 (1993)
1990 12	Pulmonary hamartoma. A clinical study of 77 cases in a 21-year period and review of literature. [2407277] Eur J Cardiothorac Surg 4(1): 15-8 (1990)
2009 13	EGFR targeted therapy in non-small cell lung cancer: potential role of cetuximab. [19707410] Biologics 3(-): 215-24 (2009)
2007 14	Review of erlotinib in the treatment of advanced non-small cell lung cancer. [19707304] Biologics 1(4): 335-46 (2007)
2010 15	The clinical effectiveness and cost-effectiveness of topotecan for small cell lung cancer: a systematic review and economic evaluation. [20356561] Health Technol Assess 14(19): 1-204 (2010)
2009 16	Erlotinib for the treatment of relapsed non-small cell lung cancer. [19567213] Health Technol Assess 13 Suppl 1(-): 41-7 (2009)
2006 17	The clinical effectiveness and cost-effectiveness of computed tomography screening for lung cancer: systematic reviews. [16409881] Health Technol Assess 10(3): iii-iv, ix-x, 1-90 (2006)
1958 18	The solitary pulmonary nodule; a review of 236 consecutive cases, 1944 to 1956. [13498640] Ann Surg 147(2): 197-202 (1958)
2008 19	First- and second-line treatment of advanced metastatic non-small-cell lung cancer: a global view. [18831719] BMC Proc 2 Suppl 2(-): S3 (2008)
2001 20	Prophylactic cranial irradiation in small cell lung cancer: a systematic review of the literature with meta-analysis. [11432756] BMC Cancer 1(-): 5 (2001)
2010 21	Systemic therapies in metastatic non-small-cell lung cancer with emphasis on targeted therapies: the rational approach. [20404973] Curr Oncol 17(2): 13-23 (2010)
2010 22	Impact of biomarkers on non-small cell lung cancer treatment. [20443070] Target Oncol 5(1): 5-17 (2010)
2009 23	Anatomy, biology and concepts, pertaining to lung cancer stage classification. [19333070] J Thorac Oncol 4(4): 437-43 (2009)
2009 24	Preinvasive lesions of the bronchus. [19279508] J Thorac Oncol 4(4): 545-51 (2009)
2008 25	Turning gray: the natural history of lung cancer over time. [18594326] J Thorac Oncol 3(7): 781-92 (2008)
2008 26	EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer. [18317074] J Thorac Oncol 3(3): 303-10 (2008)
2007 27	Chemotherapy for relapsed small cell lung cancer: a systematic review and practice guideline. [17409809] J Thorac Oncol 2(4): 348-54 (2007)
2007 28	A translational view of the molecular pathogenesis of lung cancer. [17409807] J Thorac Oncol 2(4): 327-43 (2007)
2006 29	A review of first-line treatment for small-cell lung cancer. [17409868] J Thorac Oncol 1(3): 270-8 (2006)
2008 30	Small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. [18456763] Ann Oncol 19 Suppl 2(-): ii41-2 (2008)
2008 31	Non-small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. [18456762] Ann Oncol 19 Suppl 2(-): ii39-40 (2008)
2006 32	The expanding role of systemic treatment in non-small cell lung cancer neo-adjuvant therapy. [17018710] Ann Oncol 17 Suppl 10(-): x108-12 (2006)
2006 33	Expanding role of chemotherapy in lung cancer. [17018709] Ann Oncol 17 Suppl 10(-): x101-7 (2006)
2006 34	Second-line chemotherapy for non-small cell lung cancer. [16807467] Ann Oncol 17 Suppl 5(-): v68-71 (2006)
2006 35	First line chemotherapy in advanced or metastatic NSCLC. [16807466] Ann Oncol 17 Suppl 5(-): v64-7 (2006)
2006 36	Current status of adjuvant chemotherapy in NSCLC. [16807465] Ann Oncol 17 Suppl 5(-): v62-3 (2006)
2006 37	Neo-adjuvant chemotherapy in non-small cell lung cancer (NSCLC). [16807464] Ann Oncol 17 Suppl 5(-): v55-61 (2006)
2006 38	Chemo-radiotherapy in non-small cell lung cancer: the role of gemcitabine. [16807463] Ann Oncol 17 Suppl 5(-): v52-4 (2006)
2006 39	Development of gemcitabine in non-small cell lung cancer: the Italian contribution. [16807461] Ann Oncol 17 Suppl 5(-): v37-46 (2006)
2006 40	10-year update on chemotherapy for non-small cell lung cancer. [16807460] Ann Oncol 17 Suppl 5(-): v33-36 (2006)
2006 41	Clinical studies of pemetrexed and gemcitabine combinations. [16807459] Ann Oncol 17 Suppl 5(-): v29-32 (2006)
2006 42	Prophylactic cranial irradiation in non-small cell lung cancer. [16608992] Ann Oncol 17 Suppl 2(-): ii76-78 (2006)
2006 43	Brain metastases in patients with non-small cell lung cancer: focus on the role of chemotherapy. [16608991] Ann Oncol 17 Suppl 2(-): ii73-75 (2006)
2006 44	Treatment and prophylaxis for brain metastases from non-small cell lung cancer: whole brain radiation treatment versus stereotactic radiosurgery. [16608990] Ann Oncol 17 Suppl 2(-): ii71-72 (2006)
2006 45	Maintenance chemotherapy in non-small cell lung cancer. [16608989] Ann Oncol 17 Suppl 2(-): ii67-70 (2006)
2006 46	Small cell lung cancer. [16608983] Ann Oncol 17 Suppl 2(-): ii5-10 (2006)
2006 47	Treatment of advanced non-small cell lung cancer. [16608979] Ann Oncol 17 Suppl 2(-): ii36-41 (2006)
2006 48	New radiation techniques for treatment of locally advanced non-small cell lung cancer (NSCLC). [16608978] Ann Oncol 17 Suppl 2(-): ii34-35 (2006)
2002 49	Patterns of failure after prophylactic cranial irradiation in small-cell lung cancer: analysis of 505 randomized patients. [12075744] Ann Oncol 13(5): 748-54 (2002)
2008 50	Pneumonectomy after chemoradiation: the Dana-Farber Cancer Institute/Brigham and Women's Hospital experience. [18286507] Cancer 112(5): 1106-13 (2008)
2007 51	Primary salivary gland-type lung cancer: spectrum of clinical presentation, histopathologic and prognostic factors. [17918258] Cancer 110(10): 2253-9 (2007)
2007 52	Recent improvement in the survival of patients with advanced nonsmall cell lung cancer enrolled in phase III trials of first-line, systemic chemotherapy. [17285602] Cancer 109(5): 939-48 (2007)
2006 53	Risk factors for local progression after percutaneous radiofrequency ablation of lung tumors: evaluation based on a preliminary review of 342 tumors. [17096433] Cancer 107(12): 2873-80 (2006)
2000 54	Multiple chondromatous hamartomas of the lung: a case report and review of the literature with special reference to Carney syndrome. [10679667] Cancer 88(4): 964-5 (2000)
2007 55	Adjuvant chemotherapy in elderly patients with non-small-cell lung cancer. [17242671] Cancer Control 14(1): 57-62 (2007)
2006 56	Large-cell neuroendocrine carcinoma of the lung. [17075564] Cancer Control 13(4): 270-5 (2006)
2006 57	Solitary fibrous tumor of the pleura. [17075563] Cancer Control 13(4): 264-9 (2006)
2006 58	Understanding the uncommon thoracic tumors. [17075561] Cancer Control 13(4): 252-3 (2006)
2001 59	NCCN: Small cell lung cancer. [11760556] Cancer Control 8(6 Suppl 2): 32-43 (2001)
2001 60	NCCN: Non-small cell lung cancer. [11760555] Cancer Control 8(6 Suppl 2): 22-31 (2001)
2001 61	Treatment of advanced non-small-cell lung cancer: a review of current randomized clinical trials and an examination of emerging therapies. [11483886] Cancer Control 8(4): 326-36 (2001)
2001 62	Early detection of lung cancer: clinical perspectives of recent advances in biology and radiology. [11205917] Clin Cancer Res 7(1): 5-22 (2001)
1998 63	New chemotherapeutic agents prolong survival and improve quality of life in non-small cell lung cancer: a review of the literature and future directions. [9607565] Clin Cancer Res 4(5): 1087-100 (1998)
1997 64	Combined modality therapy of lung cancer. [10068267] Clin Cancer Res 3(12 Pt 2): 2638-47 (1997)
2007 65	18Fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer: a systematic review. [18042932] J Natl Cancer Inst 99(23): 1753-67 (2007)
2007 66	Cisplatin- versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: an individual patient data meta-analysis. [17551145] J Natl Cancer Inst 99(11): 847-57 (2007)
2007 67	Cisplatin versus carboplatin for patients with metastatic non-small-cell lung cancer--an old rivalry renewed. [17551137] J Natl Cancer Inst 99(11): 828-9 (2007)
2009 68	The role of the taxanes in the treatment of older patients with advanced stage non-small cell lung cancer. [19342473] Oncologist 14(4): 412-24 (2009)
2009 69	The differential efficacy of pemetrexed according to NSCLC histology: a review of two Phase III studies. [19221167] Oncologist 14(3): 253-63 (2009)
2008 70	Consensus conference: multimodality management of early- and intermediate-stage non-small cell lung cancer. [18779538] Oncologist 13(9): 945-53 (2008)
2008 71	Critical review of nonsurgical treatment options for stage I non-small cell lung cancer. [18378542] Oncologist 13(3): 309-19 (2008)
2008 72	Considerations for second-line therapy of non-small cell lung cancer. [18263772] Oncologist 13 Suppl 1(-): 28-36 (2008)
2008 73	Local control of regional and metastatic lesions and indication for systemic chemotherapy in patients with non-small cell lung cancer. [18263771] Oncologist 13 Suppl 1(-): 21-7 (2008)
2008 74	Clinical evidence for second- and third-line treatment options in advanced non-small cell lung cancer. [18263770] Oncologist 13 Suppl 1(-): 14-20 (2008)
2008 75	Systemic chemotherapy for advanced non-small cell lung cancer: recent advances and future directions. [18263769] Oncologist 13 Suppl 1(-): 5-13 (2008)
2008 76	CT screening for lung cancer: update 2007. [18245013] Oncologist 13(1): 65-78 (2008)
2007 77	Recent advances with topotecan in the treatment of lung cancer. [17962613] Oncologist 12(10): 1194-204 (2007)
2007 78	The role of bevacizumab in the treatment of non-small cell lung cancer: current indications and future developments. [17962612] Oncologist 12(10): 1183-93 (2007)
2007 79	Erlotinib in non-small cell lung cancer treatment: current status and future development. [17673615] Oncologist 12(7): 840-9 (2007)
2007 80	Sequential, alternating, and maintenance/consolidation chemotherapy in advanced non-small cell lung cancer: a review of the literature. [17470688] Oncologist 12(4): 451-64 (2007)
2006 81	Combined modality therapy for stage III non-small cell lung cancer. [16880240] Oncologist 11(7): 809-23 (2006)
2006 82	Salvage therapy for advanced non-small cell lung cancer: factors influencing treatment selection. [16794244] Oncologist 11(6): 655-65 (2006)
2005 83	Treatment of small cell lung cancer in the elderly. [15967834] Oncologist 10(6): 399-411 (2005)
2001 84	Lung cancer. [11675518] Oncologist 6(5): 407-14 (2001)
2000 85	Prophylactic cranial irradiation in small-cell lung cancer. [10964996] Oncologist 5(4): 293-8 (2000)
2008 86	Second-line and third-line chemotherapy for lung cancer: use and cost. [18471034] Am J Manag Care 14(5): 297-306 (2008)
2004 87	Lung cancer screening with sputum cytologic examination, chest radiography, and computed tomography: an update for the U.S. Preventive Services Task Force. [15126259] Ann Intern Med 140(9): 740-53 (2004)
2004 88	Lung cancer screening: recommendation statement. [15126258] Ann Intern Med 140(9): 738-9 (2004)
2009 89	A translational approach to lung cancer research: From EGFRs to Wnt and cancer stem cells. [19763051] Ann Thorac Cardiovasc Surg 15(4): 213-20 (2009)
2008 90	Staging of lung cancer. [18321899] Chest 133(3): 593-5 (2008)
2007 91	Management of small cell lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). [17873178] Chest 132(3 Suppl): 324S-339S (2007)
2007 92	Evidence for management of small cell lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). [17873177] Chest 132(3 Suppl): 314S-323S (2007)
2007 93	Bronchioloalveolar lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). [17873176] Chest 132(3 Suppl): 306S-13S (2007)
2007 94	Special treatment issues in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). [17873175] Chest 132(3 Suppl): 290S-305S (2007)
2007 95	Treatment of non-small cell lung cancer, stage IV: ACCP evidence-based clinical practice guidelines (2nd edition). [17873174] Chest 132(3 Suppl): 277S-289S (2007)
2007 96	Treatment of non-small cell lung cancer, stage IIIB: ACCP evidence-based clinical practice guidelines (2nd edition). [17873173] Chest 132(3 Suppl): 266S-276S (2007)
2007 97	Treatment of non-small cell lung cancer-stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition). [17873172] Chest 132(3 Suppl): 243S-265S (2007)
2007 98	Treatment of non-small cell lung cancer stage I and stage II: ACCP evidence-based clinical practice guidelines (2nd edition). [17873171] Chest 132(3 Suppl): 234S-242S (2007)
2007 99	Bronchial intraepithelial neoplasia/early central airways lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). [17873170] Chest 132(3 Suppl): 221S-233S (2007)
2007 100	Invasive mediastinal staging of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). [17873169] Chest 132(3 Suppl): 202S-220S (2007)
2007 101	Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edition). [17873168] Chest 132(3 Suppl): 178S-201S (2007)
2007 102	Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: ACCP evidenced-based clinical practice guidelines (2nd edition). [17873167] Chest 132(3 Suppl): 161S-77S (2007)
2007 103	Initial evaluation of the patient with lung cancer: symptoms, signs, laboratory tests, and paraneoplastic syndromes: ACCP evidenced-based clinical practice guidelines (2nd edition). [17873166] Chest 132(3 Suppl): 149S-160S (2007)
2007 104	Initial diagnosis of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). [17873165] Chest 132(3 Suppl): 131S-148S (2007)
2007 105	Evaluation of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition). [17873164] Chest 132(3 Suppl): 108S-130S (2007)
2007 106	Evidence for the treatment of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition). [17873163] Chest 132(3 Suppl): 94S-107S (2007)
2007 107	Diagnostic surgical pathology in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). [17873162] Chest 132(3 Suppl): 78S-93S (2007)
2007 108	Screening for lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). [17873161] Chest 132(3 Suppl): 69S-77S (2007)
2006 109	Long-term survivorship in lung cancer: a review. [16608961] Chest 129(4): 1088-97 (2006)
2004 110	Malignant pleural mesothelioma: update, current management, and newer therapeutic strategies. [15486399] Chest 126(4): 1318-29 (2004)
2003 111	Surgical treatment of malignant pleural mesothelioma: a review. [12576380] Chest 123(2): 551-61 (2003)
2003 112	Initial evaluation of the patient with lung cancer: symptoms, signs, laboratory tests, and paraneoplastic syndromes. [12527569] Chest 123(1 Suppl): 97S-104S (2003)
2000 113	Diagnosis of lung cancer: pathology of invasive and preinvasive neoplasia. [10777460] Chest 117(4 Suppl 1): 80S-89S (2000)
1999 114	Advances in the treatment of malignant pleural mesothelioma. [10453882] Chest 116(2): 504-20 (1999)
1998 115	Bronchoalveolar carcinoma: histopathologic study of evolution in a series of 105 surgically treated patients. [9498957] Chest 113(2): 391-5 (1998)
1993 116	Natural history and epidemiology of malignant mesothelioma. [8462328] Chest 103(4 Suppl): 373S-376S (1993)
2002 117	Diagnostic imaging of lung cancer. [11999004] Eur Respir J 19(4): 722-42 (2002)
2001 118	The new World Health Organization classification of lung tumours. [11829087] Eur Respir J 18(6): 1059-68 (2001)
1998 119	Pulmonary epithelioid haemangioendothelioma in 21 patients, including three with partial spontaneous regression. [9701420] Eur Respir J 12(1): 89-96 (1998)
1995 120	Biological and immunological aspects of malignant mesothelioma. [7664867] Eur Respir J 8(4): 643-50 (1995)
1994 121	Serum tumour markers in lung cancer: history, biology and clinical applications. [8143820] Eur Respir J 7(1): 186-97 (1994)
2007 122	New molecularly targeted therapies for lung cancer. [17909619] J Clin Invest 117(10): 2740-50 (2007)
2006 123	Immunohistochemical markers of prognosis in non-small cell lung cancer: a review and proposal for a multiphase approach to marker evaluation. [16873561] J Clin Pathol 59(8): 790-800 (2006)
1987 124	Pulmonary adenocarcinoma: review of 106 cases and proposed new classification. [3818979] J Clin Pathol 40(2): 125-35 (1987)
2008 125	Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. [18452692] Mayo Clin Proc 83(5): 584-94 (2008)
2008 126	Small cell lung cancer. [18316005] Mayo Clin Proc 83(3): 355-67 (2008)
2009 127	Current treatments for advanced stage non-small cell lung cancer. [19349493] Proc Am Thorac Soc 6(2): 233-41 (2009)
2009 128	Adjuvant treatment of resected lung cancer. [19349488] Proc Am Thorac Soc 6(2): 194-200 (2009)
2002 129	Preneoplastic lesions of the lung. [11980589] Respir Res 3(-): 20 (2002)
1987 130	Mesenchymoma of the lung (so called hamartoma): a review of 154 parenchymal and endobronchial cases. [3321538] Thorax 42(10): 790-3 (1987)
1984 131	Alveolar carcinoma: a review. [6324408] Thorax 39(3): 166-74 (1984)
1984 132	Histological classification of lung cancer. [6324407] Thorax 39(3): 161-5 (1984)
1982 133	Diffuse malignant mesothelioma: a review. [6761970] West J Med 137(6): 548-54 (1982)
2007 134	Pictorial review of the many faces of bronchioloalveolar cell carcinoma. [17940131] Br J Radiol 80(960): 1015-23 (2007)
2001 135	Lung cancer screening. [11459725] Br J Radiol 74(882): 478-85 (2001)
2008 136	Pulmonary nodules: detection, assessment, and CAD. [18806142] AJR Am J Roentgenol 191(4): 1057-69 (2008)
2008 137	Screening for lung cancer. [18287449] AJR Am J Roentgenol 190(3): 755-61 (2008)
2007 138	Solitary pulmonary nodules: detection, characterization, and guidance for further diagnostic workup and treatment. [17179346] AJR Am J Roentgenol 188(1): 57-68 (2007)
2005 139	Detection of pulmonary nodules using a 2D HASTE MR sequence: comparison with MDCT. [16177419] AJR Am J Roentgenol 185(4): 979-84 (2005)
1994 140	Lymphoproliferative disorders of the lung: histopathology, clinical manifestations, and imaging features. [8037014] AJR Am J Roentgenol 163(2): 273-81 (1994)
1992 141	Malignant pleural mesothelioma: value of CT and MR imaging in predicting resectability. [1414807] AJR Am J Roentgenol 159(5): 961-6 (1992)
1990 142	Pitfalls in the radiologic diagnosis of lung cancer. [2110722] AJR Am J Roentgenol 154(6): 1165-75 (1990)
1990 143	Radiologic evaluation of the solitary pulmonary nodule. [2107661] AJR Am J Roentgenol 154(4): 701-8 (1990)
1983 144	Leiomyomatous lung lesions: a proposed classification. [6603116] AJR Am J Roentgenol 141(2): 269-72 (1983)
1977 145	1976 Caldwell Lecture: varying manifestation of peripheral pulmonary neoplasms: a radiologic-pathologic correlative study. [414553] AJR Am J Roentgenol 128(6): 893-914 (1977)
1976 146	Pulmonary blastoma: case report and literature review. [998819] AJR Am J Roentgenol 127(6): 1048-9 (1976)
2005 147	Utility of 18F-FDG PET in evaluating cancers of lung. [15930019] J Nucl Med Technol 33(2): 69-74; quiz 75-7 (2005)
2009 148	Cost-effectiveness of 99mTc-sestamibi in predicting response to chemotherapy in patients with lung cancer: systematic review and meta-analysis. [19223414] J Nucl Med 50(3): 376-81 (2009)
1999 149	PET in lung cancer. [10319756] J Nucl Med 40(5): 814-20 (1999)
2006 150	From the archives of the AFIP: Pleuropulmonary synovial sarcoma. [16702463] Radiographics 26(3): 923-40 (2006)
2002 151	Unusual primary lung tumors: a radiologic-pathologic overview. [12006690] Radiographics 22(3): 601-19 (2002)
2001 152	Oncodiagnosis panel: 1999. Cancer of the lung: oncodiagnosis. [11706227] Radiographics 21(6): 1573-96 (2001)
1997 153	Bronchioloalveolar carcinoma: clinical, histopathologic, and radiologic findings. [9397450] Radiographics 17(6): 1345-57 (1997)
1994 154	Bronchogenic carcinoma: radiologic-pathologic correlation. [8190965] Radiographics 14(2): 429-46; quiz 447-8 (1994)
1992 155	CT of focal pulmonary masses in childhood. [1609141] Radiographics 12(3): 505-14 (1992)
2005 156	Case report: pulmonary blastoma: presentation of two atypical cases and review of the literature. [15845939] Br J Radiol 78(929): 437-40 (2005)
2005 157	Imaging of the patient with non-small cell lung cancer. [16251391] Radiology 237(3): 803-18 (2005)
2005 158	Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. [16244247] Radiology 237(2): 395-400 (2005)
2005 159	Peripheral solitary pulmonary nodule: CT findings in patients with pulmonary emphysema. [15716392] Radiology 235(1): 266-73 (2005)
2008 160	Molecular diagnosis of lung cancer: an overview of recent developments. [18924306] Acta Biomed 79 Suppl 1(-): 11-23 (2008)
2002 161	Interventional palliative treatment options for lung cancer. [12401697] Ann Oncol 13 Suppl 4(-): 247-50 (2002)
2010 162	Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. [20555058] Ann Oncol 21 Suppl 5(-): v103-15 (2010)
2010 163	Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. [20555059] Ann Oncol 21 Suppl 5(-): v116-9 (2010)
2010 164	Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. [20555060] Ann Oncol 21 Suppl 5(-): v120-5 (2010)
2010 165	Adjuvant chemotherapy for resectable non-small-cell lung cancer: where is it going? [20943614] Ann Oncol 21 Suppl 7(-): vii196-8 (2010)
2010 166	Do we have markers to select patients for adjuvant therapies of non-small-cell lung cancer? [20943615] Ann Oncol 21 Suppl 7(-): vii199-202 (2010)
2010 167	Should we continue to use the term non-small-cell lung cancer? [20943619] Ann Oncol 21 Suppl 7(-): vii225-9 (2010)
2010 168	How to integrate current knowledge in selecting patients for first line in NSCLC? [20943620] Ann Oncol 21 Suppl 7(-): vii230-3 (2010)
2010 169	Consequences of targeted treatments for second-line therapy. [20943621] Ann Oncol 21 Suppl 7(-): vii234-40 (2010)
2010 170	Early stage non-small-cell lung cancer: challenges in staging and adjuvant treatment: evidence-based staging. [20943613] Ann Oncol 21 Suppl 7(-): vii189-95 (2010)
2009 171	Non-small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. [19454467] Ann Oncol 20 Suppl 4(-): 68-70 (2009)
2009 172	Small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. [19454469] Ann Oncol 20 Suppl 4(-): 71-2 (2009)
2010 173	Second-line treatments of advanced non-small-cell lung cancer: new evidence for clinical practice. [19920059] Ann Oncol 21(2): 428-9 (2010)
2010 174	New Response Evaluation Criteria in Solid Tumors (RECIST) guidelines for advanced non-small cell lung cancer: comparison with original RECIST and impact on assessment of tumor response to targeted therapy. [20729419] AJR Am J Roentgenol 195(3): W221-8 (2010)
2010 175	A radiologic review of the new TNM classification for lung cancer. [20173129] AJR Am J Roentgenol 194(3): 562-73 (2010)
2010 176	Multiple cystlike lung lesions in the adult. [20028879] AJR Am J Roentgenol 194(1): W1-W11 (2010)
2009 177	Staging of non-small cell lung cancer using integrated PET/CT. [19843732] AJR Am J Roentgenol 193(5): 1203-11 (2009)
2008 178	Imaging of non-small cell lung cancer of the superior sulcus: part 1: anatomy, clinical manifestations, and management. [18349457] Radiographics 28(2): 551-60; quiz 620 (2008)
2008 179	Imaging of non-small cell lung cancer of the superior sulcus: part 2: initial staging and assessment of resectability and therapeutic response. [18349458] Radiographics 28(2): 561-72 (2008)
2011 180	SEPAR guidelines for lung cancer staging. [21824707] Arch Bronconeumol 47(9): 454-65 (2011)
2011 181	Primary pulmonary mucinous cystadenocarcinoma: presentation of a case and a review of the literature. [21439701] Arch Bronconeumol 47(4): 216-7 (2011)
2004 182	The diagnosis of bronchioloalveolar carcinoma by cytologic means. [15272525] Am J Clin Pathol 122(1): 14-6 (2004)
2009 183	Micropapillary histology: a frequent morphology of mutation-associated lung adenocarcinoma? [19369618] Am J Clin Pathol 131(5): 615-7 (2009)
2005 184	The spectrum of pulmonary mucinous cystic neoplasia : a clinicopathologic and immunohistochemical study of ten cases and review of literature. [15923171] Am J Clin Pathol 124(1): 62-70 (2005)
2011 185	A systemic review of PET and biology in lung cancer. [21904658] Am J Transl Res 3(4): 383-91 (2011)
2007 186	Computed tomography screening for lung cancer. [17289689] BMJ 334(7588): 271 (2007)
2010 187	Novel insights into the molecular origins and treatment of lung cancer. [20962595] Cell Cycle 9(20): 4098-105 (2010)
2004 188	Pulmonary epithelioid hemangioendothelioma: an unusual case and a review of the literature. [14769767] Chest 125(2): 789-93 (2004)
2003 189	Lung cancer. Special treatment issues. [12527583] Chest 123(1 Suppl): 244S-258S (2003)
2003 190	Small cell lung cancer. [12527584] Chest 123(1 Suppl): 259S-271S (2003)
2010 191	PET scans for lung nodules: costs and cost-effectiveness. [20051397] Chest 137(1): 4-6 (2010)
2007 192	Complementary therapies and integrative oncology in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). [17873179] Chest 132(3 Suppl): 340S-354S (2007)
2007 193	Follow-up and surveillance of the lung cancer patient following curative intent therapy: ACCP evidence-based clinical practice guideline (2nd edition). [17873180] Chest 132(3 Suppl): 355S-367S (2007)
2009 194	The new lung cancer staging system. [19584208] Chest 136(1): 260-71 (2009)
2004 195	Malignant versus benign nodules at CT screening for lung cancer: comparison of thin-section CT findings. [15498895] Radiology 233(3): 793-8 (2004)
2009 196	Subsolid pulmonary nodules and the spectrum of peripheral adenocarcinomas of the lung: recommended interim guidelines for assessment and management. [19952025] Radiology 253(3): 606-22 (2009)
2007 197	Clinical predictors of metastatic disease to the brain from non-small cell lung carcinoma: primary tumor size, cell type, and lymph node metastases. [17229875] Radiology 242(3): 882-8 (2007)
2009 198	Pulmonary nodules: volume repeatability at multidetector CT lung cancer screening. [19380692] Radiology 251(3): 919-25 (2009)
2009 199	Noncalcified lung nodules: volumetric assessment with thoracic CT. [19332844] Radiology 251(1): 26-37 (2009)
2008 200	Microwave ablation of lung malignancies: effectiveness, CT findings, and safety in 50 patients. [18372457] Radiology 247(3): 871-9 (2008)
2008 201	Comparison of chest tomosynthesis and chest radiography for detection of pulmonary nodules: human observer study of clinical cases. [18849504] Radiology 249(3): 1034-41 (2008)
2008 202	Estimating long-term effectiveness of lung cancer screening in the Mayo CT screening study. [18458247] Radiology 248(1): 278-87 (2008)
2011 203	The role of proteasome inhibition in nonsmall cell lung cancer. [21629760] J Biomed Biotechnol 2011(-): 806506 (2011)
2011 204	Target therapies in lung cancer. [21541198] J Biomed Biotechnol 2011(-): 921231 (2011)
2009 205	Chemoprevention of lung cancer. [19349487] Proc Am Thorac Soc 6(2): 187-93 (2009)
2005 206	What are the clinical features of lung cancer before the diagnosis is made? A population based case-control study. [16227326] Thorax 60(12): 1059-65 (2005)
2003 207	Lung cancer . 3: Fluorescence bronchoscopy: clinical dilemmas and research opportunities. [12612310] Thorax 58(3): 266-71 (2003)
2007 208	Photodynamic therapy (PDT) in early central lung cancer: a treatment option for patients ineligible for surgical resection. [17090572] Thorax 62(5): 391-5 (2007)
2007 209	Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: an under-recognised spectrum of disease. [17099078] Thorax 62(3): 248-52 (2007)
2011 210	Approach to multiple pulmonary nodules: a case report and review of literature. [21479348] ScientificWorldJournal 11(-): 760-5 (2011)
2010 211	Rare causes of calcitriol-mediated hypercalcemia: a case report and literature review. [20427501] J Clin Endocrinol Metab 95(7): 3111-7 (2010)
2010 212	Gefitinib or erlotinib in the treatment of advanced non-small cell lung cancer. [20587343] Discov Med 9(49): 538-45 (2010)
2011 213	Role of Survival Post-Progression in Phase III Trials of Systemic Chemotherapy in Advanced Non-Small-Cell Lung Cancer: A Systematic Review. [22114662] PLoS One 6(11): e26646 (2011)
2011 214	Addition of bevacizumab to chemotherapy in advanced non-small cell lung cancer: a systematic review and meta-analysis. [21829644] PLoS One 6(8): e22681 (2011)
2007 215	The role of phosphoinositide 3-kinase pathway inhibitors in the treatment of lung cancer. [17671156] Clin Cancer Res 13(15 Pt 2): s4637-40 (2007)
2007 216	HKI-272 in non small cell lung cancer. [17671147] Clin Cancer Res 13(15 Pt 2): s4593-6 (2007)
2007 217	Antibodies to the epidermal growth factor receptor in non small cell lung cancer: current status of matuzumab and panitumumab. [17671148] Clin Cancer Res 13(15 Pt 2): s4597-601 (2007)
2009 218	Baseline vascular endothelial growth factor concentration as a potential predictive marker of benefit from vandetanib in non-small cell lung cancer. [19447868] Clin Cancer Res 15(10): 3600-9 (2009)
2009 219	Combined survival analysis of prospective clinical trials of gefitinib for non-small cell lung cancer with EGFR mutations. [19531624] Clin Cancer Res 15(13): 4493-8 (2009)
2009 220	Epidermal growth factor receptor inhibitors and antiangiogenic agents for the treatment of non-small cell lung cancer. [19671872] Clin Cancer Res 15(16): 5040-8 (2009)
2009 221	Lung cancer in never smokers: molecular profiles and therapeutic implications. [19755392] Clin Cancer Res 15(18): 5646-61 (2009)
2009 222	Lung cancer in never smokers: clinical epidemiology and environmental risk factors. [19755391] Clin Cancer Res 15(18): 5626-45 (2009)
2006 223	Mouse models of lung cancer. [16857817] Clin Cancer Res 12(14 Pt 2): 4396s-4402s (2006)
2010 224	Adjuvant therapy in non-small cell lung cancer: current and future directions. [20682608] Oncologist 15(8): 862-72 (2010)
2010 225	Maintenance and consolidation therapy in patients with unresectable stage III/IV non-small cell lung cancer. [20930098] Oncologist 15(10): 1034-42 (2010)
2010 226	Histology matters: individualizing treatment in non-small cell lung cancer. [20086166] Oncologist 15(1): 3-5 (2010)
2010 227	Limited-stage small cell lung cancer: current chemoradiotherapy treatment paradigms. [20145192] Oncologist 15(2): 187-95 (2010)
2010 228	Do we have enough evidence to implement particle therapy as standard treatment in lung cancer? A systematic literature review. [20067947] Oncologist 15(1): 93-103 (2010)
2007 229	Indications and developments of video-assisted thoracic surgery in the treatment of lung cancer. [17962614] Oncologist 12(10): 1205-14 (2007)
2007 230	Second-generation epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer. [17405897] Oncologist 12(3): 325-30 (2007)
2007 231	Increasing chemotherapy in small-cell lung cancer: from dose intensity and density to megadoses. [17227903] Oncologist 12(1): 79-89 (2007)
2005 232	Three emerging new drugs for NSCLC: pemetrexed, bortezomib, and cetuximab. [15821248] Oncologist 10(4): 282-91 (2005)
2009 233	Combined inhibition of the VEGFR and EGFR signaling pathways in the treatment of NSCLC. [19357226] Oncologist 14(4): 399-411 (2009)
2009 234	Vascular disrupting agents: a novel mechanism of action in the battle against non-small cell lung cancer. [19474164] Oncologist 14(6): 612-20 (2009)
2009 235	Cetuximab and other anti-epidermal growth factor receptor monoclonal antibodies in the treatment of non-small cell lung cancer. [19482958] Oncologist 14(6): 601-11 (2009)
2009 236	The role of EGFR inhibition in the treatment of non-small cell lung cancer. [19892771] Oncologist 14(11): 1116-30 (2009)
2009 237	Pulmonary neuroendocrine/carcinoid tumors: a review article. [19562772] Cancer 115(19): 4434-41 (2009)
2008 238	LKB1 and lung cancer: more than the usual suspects. [18483235] Cancer Res 68(10): 3562-5 (2008)
2006 239	Vinflunine -- an active chemotherapy for treatment of advanced non-small-cell lung cancer previously treated with a platinum-based regimen: results of a phase II study. [16641911] Br J Cancer 94(10): 1383-8 (2006)
2010 240	Phase II study of nedaplatin and irinotecan with concurrent thoracic radiotherapy in patients with locally advanced non-small-cell lung cancer. [20940720] Br J Cancer 103(9): 1325-30 (2010)
2004 241	The epidemiology of interstitial lung disease and its association with lung cancer. [15340372] Br J Cancer 91 Suppl 2(-): S3-10 (2004)
2007 242	How to evaluate the risk/benefit of trimodality therapy in locally advanced non-small-cell lung cancer. [17473830] Br J Cancer 96(10): 1498-503 (2007)
2010 243	Update in lung cancer and mesothelioma 2009. [20382800] Am J Respir Crit Care Med 181(8): 773-81 (2010)
2011 244	The morphological and molecular diagnosis of lung cancer. [21886665] Dtsch Arztebl Int 108(31-32): 525-31 (2011)
2010 245	Pemetrexed for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer. [21047489] Health Technol Assess 14(Suppl. 2): 33-9 (2010)
2010 246	Gefitinib for the first-line treatment of locally advanced or metastatic non-small cell lung cancer. [21047494] Health Technol Assess 14(Suppl. 2): 71-9 (2010)
2010 247	Pemetrexed for the first-line treatment of locally advanced or metastatic non-small cell lung cancer. [20507803] Health Technol Assess 14 Suppl 1(-): 47-53 (2010)
2010 248	Recent development of molecular-targeted drugs in lung cancer. [20847494] Intern Med 49(18): 1923-34 (2010)
2008 249	Clinical relevance of sputum cytology and chest X-ray in patients with suspected lung tumors. [18591840] Intern Med 47(13): 1199-205 (2008)
2011 250	Diagnostic value of tumor marker pro-gastrin-releasing peptide in patients with small cell lung cancer: a systematic review. [21740817] Chin Med J (Engl) 124(10): 1563-8 (2011)
2004 251	Central nervous system metastases of a pulmonary epitheloid haemangioendothelioma. [15065842] Eur Respir J 23(3): 483-6 (2004)
2009 252	Differential diagnosis and management of focal ground-glass opacities. [19047318] Eur Respir J 33(4): 821-7 (2009)
2009 253	First- and second-line therapy for advanced nonsmall cell lung cancer. [19336594] Eur Respir J 33(4): 915-30 (2009)
2005 254	Reconstruction of chest wall defects after resection of large neoplasms: ten-year experience. [17670403] Interact Cardiovasc Thorac Surg 4(3): 250-5 (2005)
2010 255	Occupational lung cancer. [21225183] J Bras Pneumol 36(6): 784-94 (2010)
2009 256	Role of immunohistochemistry in the diagnosis of lung cancer. [19466276] J Bras Pneumol 35(4): 375-82 (2009)
2008 257	Histological diagnosis of lung cancer micrometastases. [18392459] J Bras Pneumol 34(3): 127-8 (2008)
2007 258	Staging non-small cell lung cancer. [17964957] Cancer Imaging 7(-): 148-59 (2007)
2008 259	Radiofrequency ablation of pulmonary tumours: current status. [18331970] Cancer Imaging 8(-): 27-35 (2008)
2008 260	Lung tumour ablation - where are we now? [18442957] Cancer Imaging 8(-): 116-7 (2008)
2006 261	Unusual lung tumours: an illustrated review of CT features suggestive of this diagnosis. [16829468] Cancer Imaging 6(-): 72-82 (2006)
2003 262	Image-guided conformal radiation therapy planning and delivery for non-small-cell lung cancer. [12915806] Cancer Control 10(4): 277-88 (2003)
2003 263	New approaches for small-cell lung cancer: local treatments. [12915807] Cancer Control 10(4): 289-96 (2003)
2003 264	Nucleotide excision repair pathways involved in Cisplatin resistance in non-small-cell lung cancer. [12915808] Cancer Control 10(4): 297-305 (2003)
2003 265	A systematic review and lessons learned from early lung cancer detection trials using low-dose computed tomography of the chest. [12915809] Cancer Control 10(4): 306-14 (2003)
2008 266	Functional lung imaging in thoracic cancer radiotherapy. [18376378] Cancer Control 15(2): 112-9 (2008)
2004 267	Position of nuclear medicine modalities in the diagnostic workup of cancer patients: lung cancer. [15243408] Q J Nucl Med Mol Imaging 48(2): 119-42 (2004)
2010 268	Advantages of breath testing for the early diagnosis of lung cancer. [20370582] Expert Rev Mol Diagn 10(3): 255-7 (2010)
2009 269	Role of miRNAs in lung cancer. [19895222] Expert Rev Mol Diagn 9(8): 773-6 (2009)
2010 270	EGFR-mutated lung cancer: a paradigm of molecular oncology. [21165163] Oncotarget 1(7): 497-514 (2010)
2009 271	Role of 18F-FDG PET in assessment of response in non-small cell lung cancer. [19380411] J Nucl Med 50 Suppl 1(-): 31S-42S (2009)
2009 272	BRG1 and LKB1: tales of two tumor suppressor genes on chromosome 19p and lung cancer. [19176640] Carcinogenesis 30(4): 547-54 (2009)
2010 273	Gene therapy for mesothelioma and lung cancer. [20160042] Am J Respir Cell Mol Biol 42(4): 385-93 (2010)
2010 274	Asbestos, lung cancers, and mesotheliomas: from molecular approaches to targeting tumor survival pathways. [20068227] Am J Respir Cell Mol Biol 42(2): 133-9 (2010)
2011 275	Caspase 9b: a new target for therapy in non-small-cell lung cancer. [21504315] Expert Rev Anticancer Ther 11(4): 499-502 (2011)
2004 276	Bronchioloalveolar carcinoma in African Americans. [15481747] J Natl Med Assoc 96(9): 1193-8 (2004)
2011 277	Nontypeable Haemophilus influenzae in chronic obstructive pulmonary disease and lung cancer. [21407824] Int J Chron Obstruct Pulmon Dis 6(-): 113-23 (2011)
2010 278	Tumors in the lung--morphologic features and the challenge of integrating biomarker signatures into diagnostics. [21103615] Rom J Morphol Embryol 51(4): 607-14 (2010)
2009 279	Optimizing the management of advanced non-small-cell lung cancer: a personal view. [19672420] Curr Oncol 16(4): 9-21 (2009)
2008 280	Immunohistochemistry for assessment of pulmonary and pleural neoplasms: a review and update. [18784820] Int J Clin Exp Pathol 1(1): 19-31 (2008)
2005 281	The current status of sentinel lymph node mapping in non-small cell lung cancer. [15900235] Ann Thorac Cardiovasc Surg 11(2): 67-72 (2005)
2011 282	The epithelial cell and lung cancer: the link between chronic obstructive pulmonary disease and lung cancer. [21311210] Respiration 81(2): 89-104 (2011)
2011 283	Chronic obstructive pulmonary disease and lung cancer: new molecular insights. [21430413] Respiration 81(4): 265-84 (2011)
2011 284	The role of transcervical extended mediastinal lymphadenectomy for lung cancer staging. [22029462] Expert Rev Med Devices 8(6): 665-7 (2011)
2011 285	Tumor suppressors and cell-cycle proteins in lung cancer. [22007345] Patholog Res Int 2011(-): 605042 (2011)
2011 286	Advances in fine needle aspiration cytology for the diagnosis of pulmonary carcinoma. [21776344] Patholog Res Int 2011(-): 897292 (2011)
2008 287	Complications after lung radiofrequency ablation: risk factors for lung inflammation. [18208852] Br J Radiol 81(963): 244-9 (2008)
2010 288	Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancer. [20047843] Crit Rev Oncol Hematol 75(3): 173-234 (2010)
2011 289	Thermal ablation of lung tumors. [21377589] Surg Oncol Clin N Am 20(2): 369-87, ix (2011)
2008 290	Hereditary diffuse gastric cancer: association with lobular breast cancer. [18046629] Fam Cancer 7(1): 73-82 (2008)
2010 291	Endotoxin exposure and lung cancer risk: a systematic review and meta-analysis of the published literature on agriculture and cotton textile workers. [20012774] Cancer Causes Control 21(4): 523-55 (2010)
2011 292	Molecular profiles of EGFR, K-ras, c-met, and FGFR in pulmonary pleomorphic carcinoma, a rare lung malignancy. [21626008] J Cancer Res Clin Oncol 137(8): 1203-11 (2011)
2009 293	IGF-I and IGFBP-3 and the risk of lung cancer: a meta-analysis based on nested case-control studies. [19549343] J Exp Clin Cancer Res 28(-): 89 (2009)
2010 294	CyberKnife stereotactic ablative radiotherapy for lung tumors. [21070081] Technol Cancer Res Treat 9(6): 589-96 (2010)
PMC 295	Evaluation of video-assisted thoracoscopic surgery for pulmonary metastases: a meta-analysis. [24416392] PLoS One 9(1):e85329 (2014)
PMC 296	American Cancer Society lung cancer screening guidelines. [23315954] CA Cancer J Clin 63(2):107-17 (2013)
PMC 297	Diesel exhaust exposure and the risk of lung cancer-a review of the epidemiological evidence. [24473109] Int J Environ Res Public Health 11(2):1312-40 (2014)
PMC 298	Computed tomography screening for lung cancer: has it finally arrived? Implications of the national lung screening trial. [23401434] J Clin Oncol 31(8):1002-8 (2013)
PMC 299	Clinical characteristics and prognostic significance of 92 cases of patients with primary mixed-histology lung cancer. [24649262] Mol Clin Oncol 1(5):863-868 (2013)
PMC 300	Basal cell origins of smoking-induced airway epithelial disorders. [24335435] Cell Cycle 13(3):341-2 (2014)
PMC 301	Preoperative evaluation for lung cancer resection. [24672690] J Thorac Dis 6(Suppl 1):S162-6 (2014)
PMC 302	Pancoast tumors: characteristics and preoperative assessment. [24672686] J Thorac Dis 6(Suppl 1):S108-15 (2014)
PMC 303	Therapeutic modalities for Pancoast tumors. [24672693] J Thorac Dis 6(Suppl 1):S180-93 (2014)
PMC 304	Treatment of stage I lung cancer in high-risk and inoperable patients: SBRT vs. RFA vs. sublobar resection. [24790840] Ann Cardiothorac Surg 3(2):167-9 (2014)
PMC 305	Segmentectomy versus lobectomy for clinical stage IA lung adenocarcinoma. [24790838] Ann Cardiothorac Surg 3(2):153-9 (2014)
PMC 306	New techniques for assessing response after hypofractionated radiotherapy for lung cancer. [24688782] J Thorac Dis 6(4):375-86 (2014)
PMC 307	Imaging techniques for tumour delineation and heterogeneity quantification of lung cancer: overview of current possibilities. [24688776] J Thorac Dis 6(4):319-27 (2014)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Lung and bronchial system (Neoplasia).php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Lung and bronchial system (Neoplasia).php on line 92